Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1994 1
1996 1
2000 4
2001 3
2003 3
2004 2
2005 5
2006 5
2007 1
2008 2
2009 5
2010 2
2011 3
2012 2
2013 1
2014 5
2016 3
2017 4
2018 3
2019 4
2020 5
2021 5
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Efficacy of atosiban for repeated embryo implantation failure: A systematic review and meta-analysis.
Wang R, Huang H, Tan Y, Xia G. Wang R, et al. Front Endocrinol (Lausanne). 2023 Mar 23;14:1161707. doi: 10.3389/fendo.2023.1161707. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37033236 Free PMC article. Review.
This study aimed to explore the efficacy of atosiban on pregnancy outcomes of patients with RIF who received IVF-ET. ...CONCLUSION: For women who are undergoing IVF-ET and have experienced repeated embryo implantation failure, atosiban may be an important factor in …
This study aimed to explore the efficacy of atosiban on pregnancy outcomes of patients with RIF who received IVF-ET. ...CONCLUSION: F …
Usefulness of atosiban for tocolysis during external cephalic version: Systematic review and meta-analysis.
Riemma G, Schiattarella A, La Verde M, Cianci S, Savoia F, De Franciscis P, Cobellis L, Colacurci N, Morlando M. Riemma G, et al. Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:86-92. doi: 10.1016/j.ejogrb.2020.12.053. Epub 2020 Dec 31. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 33421816 Review.
CONCLUSION: The use of atosiban for tocolysis does not improve the rate of successful ECVs when compared to beta-agonists. However, atosiban was associated with a significantly lower incidence of side effects and comparable cesarean section rates....
CONCLUSION: The use of atosiban for tocolysis does not improve the rate of successful ECVs when compared to beta-agonists. However, …
Atosiban versus betamimetics in the treatment of preterm labour in Italy: clinical and economic importance of side-effects.
Wex J, Abou-Setta AM, Clerici G, Di Renzo GC. Wex J, et al. Eur J Obstet Gynecol Reprod Biol. 2011 Aug;157(2):128-35. doi: 10.1016/j.ejogrb.2011.04.009. Epub 2011 May 28. Eur J Obstet Gynecol Reprod Biol. 2011. PMID: 21620558 Review.
A systematic literature review identified randomised controlled trials (RCTs) comparing atosiban with betamimetics. Meta-analysis of nine RCTs determined that atosiban and betamimetics had similar efficacy in delaying preterm birth by at least 48 h (p=0.910). Use of …
A systematic literature review identified randomised controlled trials (RCTs) comparing atosiban with betamimetics. Meta-analysis of …
Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
Wex J, Connolly M, Rath W. Wex J, et al. BMC Pregnancy Childbirth. 2009 Jun 19;9:23. doi: 10.1186/1471-2393-9-23. BMC Pregnancy Childbirth. 2009. PMID: 19538754 Free PMC article. Review.
In the probabilistic sensitivity analysis atosiban was cost saving versus both continuous and bolus fenoterol in 87%-100% of scenarios. ...Cost savings stem from the superior safety profile of atosiban....
In the probabilistic sensitivity analysis atosiban was cost saving versus both continuous and bolus fenoterol in 87%-100% of scenario …
Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis.
van Winden TMS, Nijman TAJ, Kleinrouweler CE, Salim R, Kashanian M, Al-Omari WR, Pajkrt E, Mol BW, Oudijk MA, Roos C. van Winden TMS, et al. BMC Pregnancy Childbirth. 2022 Jul 15;22(1):567. doi: 10.1186/s12884-022-04854-1. BMC Pregnancy Childbirth. 2022. PMID: 35840927 Free PMC article.
The composite neonatal outcome occurred in 58/364 (16%) after nifedipine versus 69/359 (19%) after atosiban (OR 0.76, 95%CI 0.47-1.23). Perinatal death occurred in 14/392 (3.6%) after nifedipine versus 7/380 (1.8%) after atosiban (OR 2.0, 95%CI 0.80-5.1). Nifedipine …
The composite neonatal outcome occurred in 58/364 (16%) after nifedipine versus 69/359 (19%) after atosiban (OR 0.76, 95%CI 0.47-1.23 …
Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.
Coomarasamy A, Knox EM, Gee H, Song F, Khan KS. Coomarasamy A, et al. BJOG. 2003 Dec;110(12):1045-9. BJOG. 2003. PMID: 14664874 Review.
POPULATION: Six hundred and seventy-nine women recruited in nine randomised trials evaluating the effectiveness of nifedipine versus beta-agonists, and 852 women recruited in four trials of atosiban versus beta-agonists. There were no trials comparing nifedipine directly w …
POPULATION: Six hundred and seventy-nine women recruited in nine randomised trials evaluating the effectiveness of nifedipine versus beta-ag …
Atosiban improves the outcome of embryo transfer. A systematic review and meta-analysis of randomized and non-randomized trials.
Schwarze JE, Crosby J, Mackenna A. Schwarze JE, et al. JBRA Assist Reprod. 2020 Oct 6;24(4):421-427. doi: 10.5935/1518-0557.20200016. JBRA Assist Reprod. 2020. PMID: 32401462 Free PMC article.
OBJECTIVE: To estimate the effectiveness of Atosiban in improving the outcome after embryo transfer. The effectiveness of embryo transfer per cycle is still relatively low. ...METHODS: Data sources: A systematic review of papers in English using MEDLINE and EMBASE (1990-20 …
OBJECTIVE: To estimate the effectiveness of Atosiban in improving the outcome after embryo transfer. The effectiveness of embryo tran …
Effects of atosiban on uterine peristalsis following frozen embryo transfer: A randomized controlled trial.
Buddhabunyakan N, Sothornwit J, Seejorn K, Buppasiri P, Salang L. Buddhabunyakan N, et al. Eur J Obstet Gynecol Reprod Biol. 2021 Oct;265:96-101. doi: 10.1016/j.ejogrb.2021.08.017. Epub 2021 Aug 24. Eur J Obstet Gynecol Reprod Biol. 2021. PMID: 34478926 Clinical Trial.
DESIGN: A randomized, double-blinded, controlled trial. METHODS: Fifty infertile women were randomized into the atosiban (n = 25) and placebo group (n = 25). Women in the study group received intravenous atosiban 6.75 mg, 30 min before embryo transfer, and continued …
DESIGN: A randomized, double-blinded, controlled trial. METHODS: Fifty infertile women were randomized into the atosiban (n = 25) and …
Interventions to optimize embryo transfer in women undergoing assisted conception: a comprehensive systematic review and meta-analyses.
Tyler B, Walford H, Tamblyn J, Keay SD, Mavrelos D, Yasmin E, Al Wattar BH. Tyler B, et al. Hum Reprod Update. 2022 Jun 30;28(4):480-500. doi: 10.1093/humupd/dmac009. Hum Reprod Update. 2022. PMID: 35325124 Free PMC article.
Other pharmacological add-ons also showed a beneficial effect including granulocyte colony-stimulating factor (G-CSF: n = 4, RR 1.774, 95% CI 1.252-2.512, I2 = 0), Atosiban (n = 7, RR 1.493, 95% CI 1.184-1.882, I2 = 68.27%) and hCG (n = 17, RR 1.232, 95% CI 1.099-1.382, I2 …
Other pharmacological add-ons also showed a beneficial effect including granulocyte colony-stimulating factor (G-CSF: n = 4, RR 1.774, 95% C …
Randomized Trials of Retosiban Versus Placebo or Atosiban in Spontaneous Preterm Labor.
Saade GR, Shennan A, Beach KJ, Hadar E, Parilla BV, Snidow J, Powell M, Montague TH, Liu F, Komatsu Y, McKain L, Thornton S. Saade GR, et al. Am J Perinatol. 2021 Aug;38(S 01):e309-e317. doi: 10.1055/s-0040-1710034. Epub 2020 May 7. Am J Perinatol. 2021. PMID: 32380566 Clinical Trial.
The placebo-controlled trial enrolled 23 participants (February 2016-July 2017; 2.6% of target);the atosiban-comparator trial enrolled 97 (March 2015-August 2017; 29% of target). ...Two and four neonates in the retosiban and placebo groups, respectively, had 1 component of …
The placebo-controlled trial enrolled 23 participants (February 2016-July 2017; 2.6% of target);the atosiban-comparator trial enrolle …
71 results